130 related articles for article (PubMed ID: 37066307)
1. Myelodysplastic syndromes disable human CD271+VCAM1+CD146+ niches supporting normal hematopoietic stem/progenitor cells.
Kawano Y; Kawano H; Ghoneim D; Fountaine TJ; Byun DK; LaMere MW; Mendler JH; Ho TC; Salama NA; Myers JR; Hussein SE; Frisch BJ; Ashton JM; Azadniv M; Liesveld JL; Kfoury Y; Scadden DT; Becker MW; Calvi LM
bioRxiv; 2023 Apr; ():. PubMed ID: 37066307
[TBL] [Abstract][Full Text] [Related]
2. Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow.
Flores-Figueroa E; Varma S; Montgomery K; Greenberg PL; Gratzinger D
Lab Invest; 2012 Sep; 92(9):1330-41. PubMed ID: 22710983
[TBL] [Abstract][Full Text] [Related]
3. Remodeled CD146
Chen C; Zhang M; Li R; Yuan J; Yan J; Zhang Y; Xing W; Bai J; Zhou Y
Stem Cell Rev Rep; 2023 Feb; 19(2):406-416. PubMed ID: 36018465
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes.
Bains AK; Behrens Wu L; Rivière J; Rother S; Magno V; Friedrichs J; Werner C; Bornhäuser M; Götze KS; Cross M; Platzbecker U; Wobus M
Front Oncol; 2022; 12():961473. PubMed ID: 36158640
[TBL] [Abstract][Full Text] [Related]
5. The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression.
Kfoury YS; Ji F; Jain E; Mazzola M; Schiroli G; Papazian A; Mercier F; Sykes DB; Kiem A; Randolph M; Calvi LM; Abdel-Wahab O; Sadreyev RI; Scadden DT
Blood Adv; 2023 Nov; 7(21):6608-6623. PubMed ID: 37450380
[TBL] [Abstract][Full Text] [Related]
6. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
7. Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cells.
Wobus M; Mies A; Asokan N; Oelschlägel U; Möbus K; Winter S; Cross M; Weidner H; Rauner M; Hofbauer LC; Bornhäuser M; Platzbecker U
Leukemia; 2021 Oct; 35(10):2936-2947. PubMed ID: 34002031
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
9. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
Mattiucci D; Maurizi G; Leoni P; Poloni A
Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
[TBL] [Abstract][Full Text] [Related]
10. The microenvironment in myelodysplastic syndromes: Niche-mediated disease initiation and progression.
Li AJ; Calvi LM
Exp Hematol; 2017 Nov; 55():3-18. PubMed ID: 28826860
[TBL] [Abstract][Full Text] [Related]
11. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization.
Tormin A; Li O; Brune JC; Walsh S; Schütz B; Ehinger M; Ditzel N; Kassem M; Scheding S
Blood; 2011 May; 117(19):5067-77. PubMed ID: 21415267
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow niche in the myelodysplastic syndromes.
Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
[TBL] [Abstract][Full Text] [Related]
13. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
[TBL] [Abstract][Full Text] [Related]
14. Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein.
Qian H; Le Blanc K; Sigvardsson M
J Biol Chem; 2012 Jul; 287(31):25795-807. PubMed ID: 22654106
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of aberrant hematopoietic and stromal elements in myelodysplastic syndromes.
Abbas S; Kini A; Srivastava VM; M MT; Nair SC; Abraham A; Mathews V; George B; Kumar S; Venkatraman A; Srivastava A
Blood Cells Mol Dis; 2017 Jul; 66():37-46. PubMed ID: 28822917
[TBL] [Abstract][Full Text] [Related]
16. Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium.
Altrock E; Sens-Albert C; Hofmann F; Riabov V; Schmitt N; Xu Q; Jann JC; Rapp F; Steiner L; Streuer A; Nowak V; Obländer J; Weimer N; Palme I; Göl M; Darwich A; Wuchter P; Metzgeroth G; Jawhar M; Hofmann WK; Nowak D
Stem Cell Res Ther; 2023 Jun; 14(1):156. PubMed ID: 37287056
[TBL] [Abstract][Full Text] [Related]
17. Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome.
Balderman SR; Li AJ; Hoffman CM; Frisch BJ; Goodman AN; LaMere MW; Georger MA; Evans AG; Liesveld JL; Becker MW; Calvi LM
Blood; 2016 Feb; 127(5):616-25. PubMed ID: 26637787
[TBL] [Abstract][Full Text] [Related]
18. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome.
Zhang YZ; Zhao DD; Han XP; Jin HJ; Da WM; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):813-8. PubMed ID: 18718067
[TBL] [Abstract][Full Text] [Related]
19. Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis.
Wenk C; Garz AK; Grath S; Huberle C; Witham D; Weickert M; Malinverni R; Niggemeyer J; Kyncl M; Hecker J; Pagel C; Mulholland CB; Müller-Thomas C; Leonhardt H; Bassermann F; Oostendorp RAJ; Metzeler KH; Buschbeck M; Götze KS
Blood Adv; 2018 Dec; 2(23):3447-3461. PubMed ID: 30518537
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and Cytogenetic Characterization of Mesenchymal Stromal Cells in
Rathnayake AJ; Goonasekera HW; Dissanayake VH
Anal Cell Pathol (Amst); 2016; 2016():8012716. PubMed ID: 27660743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
